Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIGGERBEST
NCT07816562Phase 3Recruiting
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Sep 2024
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 3 trial of follitropin delta in Diminished Ovarian Reserve (DOR), sponsored by INCLIVA Biomedical Research Institute. Started Sep 2024; status: recruiting.
02
Drugs
follitropin delta
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT07816562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816562.